In China, drug quality audits are primarily conducted by the National Medical Products Administration (NMPA), which oversees the regulation and supervision of pharmaceuticals. Additionally, local provincial and municipal drug regulatory authorities assist in ensuring compliance with national standards, conducting inspections, and enforcing quality control measures across the pharmaceutical industry.